Tyra Biosciences develops oral small molecule drug candidates for cancers and genetically defined conditions, based in Carlsbad, California. It last closed at $20.12 on Nov 20, up 1.98% on the day. The next earnings report for TYRA is expected around Mon, Mar 1, 2027, after the close. For the quarter ended Sep 2026, TYRA reported EPS of -$0.74. Over its last 8 reports the stock moved an average of 4.7% the session after earnings. Over the last 12 months TYRA insiders bought $20K of stock on the open market and sold $6.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is TYRA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold TYRA.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on TYRAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
TYRA · as of the Nov 20 close · updated each morning
Downtrend
The stock is 3% below its 20 day and 6% below its 50 day average. It is 45% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 45). The nearest support is the swing low (Oct 27) at $20.05, and the nearest resistance the Pivot R1 at $20.55.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 5.6%/day
Key levels
$40.6552 week high+102.0%
$29.14200 day average+44.8%
$24.85100 day average+23.5%
$22.37Swing high (Oct 29)+11.2%
$21.2750 day average+5.7%
$20.7720 day average+3.2%
$20.55Pivot R1+2.1%
$20.12Last close
$20.05Swing low (Oct 27)−0.3%
$20.01Pivot−0.5%
$19.58Pivot S1−2.7%
$16.8652 week low−16.2%
Indicators
RSI (14)
45.29
Middle of its range
Neutral
MACD
-0.40
Below its signal line
Bearish
Stochastic
15.0
Near the bottom of its range
Oversold
ADX (14)
9.1
No clear trend
Williams %R
-77.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
-82.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−4.9%
Change over 10 sessions
Bearish
ATR (14)
$1.13
Typical daily range, 5.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 16.9%/day
Key levels
$40.6552 week high+102.0%
$29.14200 day average+44.8%
$24.85100 day average+23.5%
$22.37Swing high (Oct 29)+11.2%
$21.2750 day average+5.7%
$20.7720 day average+3.2%
$20.55Pivot R1+2.1%
$20.12Last close
$20.05Swing low (Oct 27)−0.3%
$20.01Pivot−0.5%
$19.58Pivot S1−2.7%
$16.8652 week low−16.2%
Indicators
RSI (14)
40.45
Middle of its range
Neutral
MACD
-2.57
Below its signal line
Bearish
Stochastic
17.3
Near the bottom of its range
Oversold
ADX (14)
26.1
Trending down
Williams %R
-83.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-84.2
Oversold below −100, overbought above 100
Neutral
Rate of change
−8.7%
Change over 10 sessions
Bearish
ATR (14)
$3.39
Typical daily range, 16.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for TYRA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how TYRA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow TYRA usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for TYRAHow many large options trades hit TYRA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in TYRA in the last 90 days.
From SEC Form 4 filings by TYRA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TYRA is in one of them and how their past TYRA trades turned out.
Tyra Biosciences is a biotechnology company based in Carlsbad, California. It develops oral medicines for urothelial cancers, which affect the bladder and urinary tract, and for achondroplasia, a bone growth condition in children. Its drug candidates are still in clinical trials and have not been approved for sale. The company designs them with its own in-house platform, aiming to serve patients with these cancers and conditions.